- Home
- OI vs PRCT Comparison
OI vs PRCT Comparison
Compare OI & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OI
- PRCT
- Stock Information
- Founded
- OI 1903
- PRCT 2009
- Country
- OI United States
- PRCT United States
- Employees
- OI N/A
- PRCT N/A
- Industry
- OI Containers/Packaging
- PRCT Medical Specialities
- Sector
- OI Consumer Discretionary
- PRCT Health Care
- Exchange
- OI Nasdaq
- PRCT Nasdaq
- Market Cap
- OI 1.9B
- PRCT 1.8B
- IPO Year
- OI N/A
- PRCT 2021
- Fundamental
- Price
- OI $12.60
- PRCT $35.34
- Analyst Decision
- OI Buy
- PRCT Buy
- Analyst Count
- OI 7
- PRCT 8
- Target Price
- OI $16.14
- PRCT $67.14
- AVG Volume (30 Days)
- OI 1.3M
- PRCT 1.1M
- Earning Date
- OI 11-04-2025
- PRCT 11-04-2025
- Dividend Yield
- OI N/A
- PRCT N/A
- EPS Growth
- OI N/A
- PRCT N/A
- EPS
- OI N/A
- PRCT N/A
- Revenue
- OI $6,482,000,000.00
- PRCT $274,950,000.00
- Revenue This Year
- OI $1.90
- PRCT $48.38
- Revenue Next Year
- OI $1.05
- PRCT $30.87
- P/E Ratio
- OI N/A
- PRCT N/A
- Revenue Growth
- OI N/A
- PRCT 55.71
- 52 Week Low
- OI $9.23
- PRCT $32.11
- 52 Week High
- OI $16.04
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- OI 53.39
- PRCT 50.91
- Support Level
- OI $12.00
- PRCT $34.32
- Resistance Level
- OI $12.38
- PRCT $36.69
- Average True Range (ATR)
- OI 0.38
- PRCT 1.73
- MACD
- OI 0.09
- PRCT 0.41
- Stochastic Oscillator
- OI 91.78
- PRCT 82.10
About OI O-I Glass Inc.
O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.